234 related articles for article (PubMed ID: 37124778)
1. Corporate financialization, financing constraints, and innovation efficiency-Empirical evidence based on listed Chinese pharmaceutical companies.
Zhu J; Tang Y; Wei Y; Wang S; Chen Y
Front Public Health; 2023; 11():1085148. PubMed ID: 37124778
[TBL] [Abstract][Full Text] [Related]
2. How High-Polluting Firms Suffer from Being Distracted form Intended Purpose: A Corporate Social Responsibility Perspective.
Zhao XZ; Chen J; Chen FW; Wang W; Xia S
Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33317027
[TBL] [Abstract][Full Text] [Related]
3. The impact of subscribing to directors' and officers' liability insurance on corporate financialization: Evidence from China.
Peng C; Fu W; Zhang X; Jiang H
Front Psychol; 2022; 13():986135. PubMed ID: 36186362
[TBL] [Abstract][Full Text] [Related]
4. The effect of enterprise financialization on green innovation: evidence from Chinese A-share non-financial listed enterprises.
Li W; Chen L; He S
Environ Sci Pollut Res Int; 2023 Apr; 30(19):56802-56817. PubMed ID: 36929262
[TBL] [Abstract][Full Text] [Related]
5. Do local governments' energy-saving target constraints inhibit financialization? Evidence from nonfinancial listed firms in China.
Hu G; Yu Y; Wang Q
PLoS One; 2023; 18(5):e0285342. PubMed ID: 37205686
[TBL] [Abstract][Full Text] [Related]
6. Environmental regulation, digital finance, and technological innovation: evidence from listed firms in China.
Yang Y; Li X
Environ Sci Pollut Res Int; 2023 Mar; 30(15):44625-44639. PubMed ID: 36696056
[TBL] [Abstract][Full Text] [Related]
7. Influence of Financialization of Heavily Polluting Enterprises on Technological Innovation under the Background of Environmental Pollution Control.
Zhou Y; Du Y; Lei F; Su Z; Feng Y; Li J
Int J Environ Res Public Health; 2021 Dec; 18(24):. PubMed ID: 34948935
[TBL] [Abstract][Full Text] [Related]
8. The effect of the new Environmental Protection Law on corporate financialization in China.
Xie G; Yang Y; Jiang K; Chen Z
Environ Sci Pollut Res Int; 2022 Nov; 29(55):83596-83611. PubMed ID: 35764736
[TBL] [Abstract][Full Text] [Related]
9. Does digital finance improve the green investment of Chinese listed heavily polluting companies? The perspective of corporate financialization.
Jiang Y; Guo C; Wu Y
Environ Sci Pollut Res Int; 2022 Oct; 29(47):71047-71063. PubMed ID: 35595899
[TBL] [Abstract][Full Text] [Related]
10. The impact of tax reduction on enterprises' financialization-A quasi-natural experiment based on the reduction of VAT rate.
Duan S; Lu Y; Cheng Y; Liu Q
PLoS One; 2023; 18(12):e0293385. PubMed ID: 38128033
[TBL] [Abstract][Full Text] [Related]
11. How Labor Costs Affect Innovation Output in Pharmaceutical Companies: Evidence from China.
Chen Y; He Q; Wang T
Inquiry; 2024; 61():469580241246965. PubMed ID: 38726640
[TBL] [Abstract][Full Text] [Related]
12. Political turnover and corporate financialization: Evidence from China.
Lyu S; Qi Y; Yang S; Dong S
Front Psychol; 2022; 13():1039560. PubMed ID: 36389499
[TBL] [Abstract][Full Text] [Related]
13. Investigating the Relationship Between Entity Financialization, Managers' Incentives, and Enterprise's Innovation: Fresh Evidence From China.
Xu C; Zhang H; Wang M; Iqbal A
Front Psychol; 2021; 12():810294. PubMed ID: 35308072
[TBL] [Abstract][Full Text] [Related]
14. Can digital finance boost SME innovation by easing financing constraints?: Evidence from Chinese GEM-listed companies.
Yao L; Yang X
PLoS One; 2022; 17(3):e0264647. PubMed ID: 35239717
[TBL] [Abstract][Full Text] [Related]
15. Is there a moderate range of impact of financialization on corporate R&D?
Li Z; Wang Y
PLoS One; 2021; 16(6):e0253380. PubMed ID: 34191824
[TBL] [Abstract][Full Text] [Related]
16. Financial constraints, government subsidies, and corporate innovation.
Li Q; Wang J; Cao G; Zhang J
PLoS One; 2021; 16(11):e0259642. PubMed ID: 34758030
[TBL] [Abstract][Full Text] [Related]
17. Environmental regulation and corporate financialization: insight from Blue Sky Protection Campaign in China.
Zhou Z; Xu L; Guo P; Ai H
Environ Sci Pollut Res Int; 2023 Apr; 30(19):54993-55008. PubMed ID: 36881229
[TBL] [Abstract][Full Text] [Related]
18. Executive pharmaceutical background, R&D investment and corporate innovation performance.
Zhang L; Li S; Wu M
Am J Transl Res; 2023; 15(11):6576-6586. PubMed ID: 38074834
[TBL] [Abstract][Full Text] [Related]
19. Digital finance and green innovation efficiency: empirical data from Chinese listed manufacturing companies.
Lu H; Cheng Z
Environ Sci Pollut Res Int; 2024 Jan; 31(1):371-383. PubMed ID: 38012496
[TBL] [Abstract][Full Text] [Related]
20. Digital transformation and corporate financialization in emerging markets: Evidence from China.
Fang X; Ju C
Heliyon; 2024 Jan; 10(2):e24616. PubMed ID: 38298705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
